1. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial. Issue 6 (June 2017) Authors: McAuley, Daniel F; Cross, LJ Mark; Hamid, Umar; Gardner, Evie; Elborn, J Stuart; Cullen, Kathy M; Dushianthan, Ahilanandan; Grocott, Michael PW; Matthay, Michael A; O'Kane, Cecilia M Journal: Lancet Issue: Volume 5:Issue 6(2017) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗